Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Cancer Centers of the Carolinas Easley, SC
mi
from
Easley, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Cancer Centers of the Carolinas Easley, SC
mi
from
Easley, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
St. Francis Hospital
mi
from
Roslyn, NY
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
St. Francis Hospital
mi
from
Roslyn, NY
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Cancer Centers of the Carolinas - Eastside
mi
from
Greenville, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Cancer Centers of the Carolinas - Eastside
mi
from
Greenville, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Cancer Centers of the Carolinas - Faris Road
mi
from
Greenville, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Cancer Centers of the Carolinas - Faris Road
mi
from
Greenville, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Greenville Hospital System Univeristy Medical Center
mi
from
Greenville, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Greenville Hospital System Univeristy Medical Center
mi
from
Greenville, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Self Regional Cancer Center at Self Regional Medical Center
mi
from
Greenwood, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Self Regional Cancer Center at Self Regional Medical Center
mi
from
Greenwood, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Cancer Centers of the Carolinas - Greer Medical Oncology
mi
from
Greer, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Cancer Centers of the Carolinas - Greer Medical Oncology
mi
from
Greer, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Cancer Centers of the Carolinas - Seneca
mi
from
Seneca, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Cancer Centers of the Carolinas - Seneca
mi
from
Seneca, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Cancer Centers of the Carolinas - Spartanburg
mi
from
Spartanburg, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Cancer Centers of the Carolinas - Spartanburg
mi
from
Spartanburg, SC
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Medical X-Ray Center, PC
mi
from
Sioux Falls, SD
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Sanford USD Medical Center
mi
from
Sioux Falls, SD
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Sanford USD Medical Center
mi
from
Sioux Falls, SD
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
University of Texas - Southwest
mi
from
Dallas, TX
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
University of Texas - Southwest
mi
from
Dallas, TX
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Parkland Health & Hospital Systems
mi
from
Dallas, TX
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Parkland Health & Hospital Systems
mi
from
Dallas, TX
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas
mi
from
Dallas, TX
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
St. Joseph's Hospital
mi
from
Ann Arbor, MI
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
St. Joseph's Hospital
mi
from
Ann Arbor, MI
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Olympic Hematology and Oncology
mi
from
Bremerton, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Olympic Hematology and Oncology
mi
from
Bremerton, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Kadlec Hematology & Oncology
mi
from
Kennewick, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Harrison Poulsbo Hematology and Onocology
mi
from
Poulsbo, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Harrison Poulsbo Hematology and Onocology
mi
from
Poulsbo, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
University of Washington; UW Medical Center
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
University of Washington; UW Medical Center
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
University Cancer Center at University of Washington Medical Center
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
University Cancer Center at University of Washington Medical Center
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Fred Hutchinson Cancer Research Center
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Minor and James Medical, PLLC
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Minor and James Medical, PLLC
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Group Health Capitol Hill Campus
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Group Health Capitol Hill Campus
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Polyclinic First Hill
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Polyclinic First Hill
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Swedish Cancer Center
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Swedish Cancer Center
mi
from
Seattle, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Cancer Care Northwest - Spokane South
mi
from
Spokane, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Cancer Care Northwest - Spokane South
mi
from
Spokane, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Evergreen Hematology & Oncology
mi
from
Spokane, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Evergreen Hematology & Oncology
mi
from
Spokane, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Madigan Army Medical Center
mi
from
Fort Lewis-DuPont, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Madigan Army Medical Center
mi
from
Fort Lewis-DuPont, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Wenatchee Valley Medical Center
mi
from
Wenatchee, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Wenatchee Valley Medical Center
mi
from
Wenatchee, WA
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Columbia Saint Mary's Hospital - Ozaukee
mi
from
Mequon, WI
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Columbia Saint Mary's Hospital - Ozaukee
mi
from
Mequon, WI
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Columbia-Saint Mary's Cancer Care Center
mi
from
Milwaukee, WI
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Columbia-Saint Mary's Cancer Care Center
mi
from
Milwaukee, WI
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Rocky Mountain Oncology
mi
from
Casper, WY
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Rocky Mountain Oncology
mi
from
Casper, WY
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Welch Cancer Center
mi
from
Sheridan, WY
Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer
Phase III Trial of LHRH Analog Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer
Status: Archived
Updated: 1/1/1970
Welch Cancer Center
mi
from
Sheridan, WY
Breast Duct Lavage, Breast Duct Endoscopy, and Gene Expression Profiling in Women With Breast Cancer or Healthy Women Who Are and Are Not at High Risk for Breast Cancer
Characterization Of High Risk Breast Duct Epithelium By Cytology, Breast Duct Endoscopy, And cDNA Gene Expression Profile
Status: Archived
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Breast Duct Lavage, Breast Duct Endoscopy, and Gene Expression Profiling in Women With Breast Cancer or Healthy Women Who Are and Are Not at High Risk for Breast Cancer
Characterization Of High Risk Breast Duct Epithelium By Cytology, Breast Duct Endoscopy, And cDNA Gene Expression Profile
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Inflammatory Breast Cancer and Tumor Markers
Evaluation of Angiogenesis Parameters and Tumor Markers in Inflammatory Breast Cancer Specimens
Status: Archived
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Inflammatory Breast Cancer and Tumor Markers
Evaluation of Angiogenesis Parameters and Tumor Markers in Inflammatory Breast Cancer Specimens
Status: Archived
Updated: 1/1/1970
National Cancer Institute (NCI)
mi
from
Bethesda, MD
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Glendale Memorial Hospital
mi
from
Glendale, CA
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Updated: 1/1/1970
Glendale Memorial Hospital
mi
from
Glendale, CA
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Clinical Trial Facility
mi
from
Santa Clara, CA
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Updated: 1/1/1970
Clinical Trial Facility
mi
from
Santa Clara, CA
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Hollywood Presbyterian Medical Center
mi
from
Los Angeles, CA
Vaccine Therapy in Treating Patients With HER2/Neu Positive or Negative Stage IV Breast Cancer or Other HER2/Neu Positive Cancers
A Phase 1-2 Study for Stage IV Breast and HER2/Neu Positive Cancers to Evaluate the Safety and Efficacy of a Vaccine Using Whole Cells From the SVBR- 1-GM Cell Line Genetically Engineered To Produce Granulocyte- Macrophage Colony Stimulating Factor
Status: Archived
Updated: 1/1/1970
Hollywood Presbyterian Medical Center
mi
from
Los Angeles, CA
IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer
A Phase I Prevention Trial of ACTIVIN Grape Seed Extract as an Aromatase Inhibitor In Healthy Postmenopausal Women at Risk for Breast Cancer
Status: Archived
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
IH636 Grape Seed Extract in Preventing Breast Cancer in Postmenopausal Women at Risk of Developing Breast Cancer
A Phase I Prevention Trial of ACTIVIN Grape Seed Extract as an Aromatase Inhibitor In Healthy Postmenopausal Women at Risk for Breast Cancer
Status: Archived
Updated: 1/1/1970
City of Hope Comprehensive Cancer Center
mi
from
Duarte, CA
Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities
Improving the Delivery of Effective Care to Minorities
Status: Archived
Mount Sinai Hospital
mi
from
New York, NY
Reducing Underuse of Early-Stage Breast Cancer Treatment in Minority Communities
Improving the Delivery of Effective Care to Minorities
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC(Trademark)-V (Vaccinia) and PANVAC(Trademark)-F (Fowlpox) in Adults With Metastatic Breast Cancer
Status: Archived
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC(Trademark)-V (Vaccinia) and PANVAC(Trademark)-F (Fowlpox) in Adults With Metastatic Breast Cancer
Status: Archived
Updated: 1/1/1970
National Institutes of Health Clinical Center
mi
from
Bethesda, MD
Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC(Trademark)-V (Vaccinia) and PANVAC(Trademark)-F (Fowlpox) in Adults With Metastatic Breast Cancer
Status: Archived
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Docetaxel Alone or in Combination With Vaccine to Treat Breast Cancer
A Randomized Pilot Phase II Study of Docetaxel Alone or in Combination With PANVAC(Trademark)-V (Vaccinia) and PANVAC(Trademark)-F (Fowlpox) in Adults With Metastatic Breast Cancer
Status: Archived
Updated: 1/1/1970
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
A Phase II Trial of Exemestane (Aromasin) in Combination With Celecoxib (Celebrex) as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
Status: Archived
Ohio State University
mi
from
Columbus, OH
Exemestane With Celecoxib as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
A Phase II Trial of Exemestane (Aromasin) in Combination With Celecoxib (Celebrex) as Neoadjuvant Treatment in Postmenopausal Women With Stage II, III, and IV Breast Cancer
Status: Archived
Updated: 1/1/1970
Ohio State University
mi
from
Columbus, OH
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Mount Sinai Hospital
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Mount Sinai Hospital
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Columbia Presbyterian Med Ctr
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Albert Einstein College of Medicine
mi
from
Bronx, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Albert Einstein College of Medicine
mi
from
Bronx, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Harlem Hospital, Columbia University
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Harlem Hospital, Columbia University
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Metropolitan Hosp. NICHD CRS
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Metropolitan Hosp. NICHD CRS
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Montefiore Medical Center
mi
from
Bronx, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
Montefiore Medical Center
mi
from
Bronx, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
North General Hospital
mi
from
New York, NY
Patient Centered Randomized Controlled Trial
Patient Assistance to Reduce Breast Cancer Disparities
Status: Archived
Updated: 1/1/1970
North General Hospital
mi
from
New York, NY